Lawrence G. Hamann
individual
About
Lawrence G. Hamann, Ph.D., is a medicinal chemist and biotech executive who co-founded Interdict Bio and serves as its President and CEO. Earlier, he held senior drug-discovery leadership roles at Takeda, Celgene/Bristol Myers Squibb, Novartis, Bristol-Myers Squibb, and Ligand Pharmaceuticals. Publicly, he appears primarily as a drug-discovery operator, scientific leader, and advisor rather than as a documented investor or fund manager.
Areas of interest
biotechdrug discoverymedicinal chemistrychemical biologyoncologyneurodegenerationimmunologymetabolic diseasevirology